Prasetyawaty, F., Trisya, M. (2026). Polatuzumab-R-CHP vs R-CHOP in older DLBCL: Survival benefit, infectious toxicity, and cost implications in middle-income health systems.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.246